2,6,9-trisubstituted purines: optimization towards highly potent and selective CDK1 inhibitors.
Novel 2,6,9-substituted purine derivatives represent a class of potent and selective inhibitors of CDK1/cyclinB. The synthesis, SAR and biological profile of selected compounds are described.